Home R&D Page 6

R&D

Negative opinion for anamorelin hydrochloride

Results from EMBRACA Phase 3 trial in breast cancer

Erenumab to prevent migraine: results from phase III STRIBE

New orphan drug for high grade serous epithelial ovarian cancer

Haemophilia A: rurioctocog alfa pegol recommended by CHMP

Positive results of phase 2 trial on nivolumab/ipilimumab Combo in SCLC

Negative topline results of intepirdine phase 3 MINDSET trial in Alzheimer’s...

Alzheimer’s disease: trigriluzole phase 2 trial in collaboration with ADCS

NBTXR3 will be tested in combination with immune checkpoints inhibitors

A monoclonal antibody to treat atopic dermatitis

1...567...17Page 6 of 17
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151